Hypokalemia

• CLINICAL_TRIALS trial_result · 2026-02-12
  Clinical Trial Update: Potassium Supplementation in CKD [NA]

  This clinical trial update indicates an active-not-recruiting study at Erasmus Medical Center evaluating potassium supplementation in chroni…

• FDA approval · 2026-01-17
  FDA Approved: POTASSIUM CHLORIDE IN SODIUM CHLORIDE — Supplemental Application (B. Braun Medical Inc.)

  FDA approved a supplemental application for Potassium Chloride in Sodium Chloride (Sodium Chloride and Potassium Chloride) from B. Braun Med…

• FDA approval · 2025-11-20
  FDA Approved: POTASSIUM CHLORIDE — Original Application (Aurobindo Pharma Limited)

  FDA approved Aurobindo Pharma Limited's original application for a generic potassium chloride product, used to treat potassium deficiency (h…

• FDA approval · 2025-09-10
  FDA Approved: POTASSIUM CHLORIDE — Original Application (Macleods Pharmaceuticals Limited)

  FDA approved Potassium Chloride from Macleods Pharmaceuticals Limited under an Original Application; it is a generic potassium supplement in…

• FDA approval · 2025-07-11
  FDA Approved: POTASSIUM CHLORIDE — Original Application (Guardian Drug Company)

  FDA approved the original application for potassium chloride, a generic product manufactured by Guardian Drug Company.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2025-06-06
  Clinical Trial Update: Tissue Sodium Quantification in Patients With Primary Aldosteronism: See Sodium to Treat

  This clinical trial update reports ongoing recruitment for a study assessing tissue sodium quantification in patients with primary aldostero…

• FDA approval · 2025-04-09
  FDA Approved: POTASSIUM CHLORIDE — Original Application (Camber Pharmaceuticals, Inc.)

  FDA approved Camber Pharmaceuticals' generic Potassium Chloride under an Original Application (ANDA) for potassium supplementation.

• FDA approval · 2025-02-21
  FDA Approved: SPIRONOLACTONE — Original Application (Camber Pharmaceuticals, Inc.)

  The FDA approved Camber Pharmaceuticals' original application for spironolactone, establishing a generic version of the diuretic. Spironolac…

• CLINICAL_TRIALS research · 2024-12-16
  Clinical Trial Update: the Cardioprotective Effects of Improving Potassium Variability in Maintenance Hemodialysis Patients [Phase 4]

  Phase 4 clinical trial update evaluating whether improving potassium variability provides cardioprotection in patients undergoing maintenanc…

• FDA approval · 2024-11-27
  FDA Approved: POTASSIUM ACETATE — Original Application (Fresenius Kabi USA, LLC)

  The FDA approved Fresenius Kabi USA, LLC's original application for potassium acetate, a generic electrolyte supplement, for marketing in th…

• CLINICAL_TRIALS trial_result · 2024-09-19
  Clinical Trial Update: Artificial Intelligence Identified Dyskalemia Using Electrocardiogram (AIDE) [NA]

  The AIDE study completed, evaluating an AI approach to identify dyskalemia from electrocardiograms in patients with hyperkalemia or hypokale…

• FDA label_change · 2024-08-22
  FDA Approved: POTASSIUM CHLORIDE — Supplemental Application (Advagen Pharma Ltd)

  The FDA approved a supplemental application for Potassium Chloride submitted by Advagen Pharma Ltd, indicating an approved modification to t…

• FDA label_change · 2024-06-13
  FDA Approved: POTASSIUM CHLORIDE — Supplemental Application (Baxter Healthcare Corporation)

  The FDA approved a supplemental application for Potassium Chloride from Baxter Healthcare Corporation, indicating a labeling update for this…

• FDA approval · 2024-01-05
  FDA Approved: POTASSIUM CHLORIDE — Supplemental Application (Kesin Pharma Corporation)

  FDA approved a supplemental application for Potassium Chloride (oral) from Kesin Pharma Corporation. This confirms changes to an already app…

• FDA approval · 2023-12-19
  FDA Approved: POTASSIUM CHLORIDE EXTENDED RELEASE — Original Application (Rising Pharma Holdings, Inc.)

  FDA approved an original ANDA for Potassium Chloride Extended Release, a generic potassium chloride product from Rising Pharma Holdings, Inc…

• FDA approval · 2023-07-12
  FDA Approved: POTASSIUM CHLORIDE — Original Application (ANI Pharmaceuticals, Inc.)

  FDA approves ANI Pharmaceuticals' original ANDA for potassium chloride, a generic product used to prevent or treat potassium deficiency.

• FDA approval · 2023-06-28
  FDA Approved: SPIRONOLACTONE — Supplemental Application (Amneal Pharmaceuticals LLC)

  The FDA approved a supplemental application for Spironolactone from Amneal Pharmaceuticals LLC.

• FDA approval · 2023-06-16
  FDA Approved: POTASSIUM CHLORIDE — Original Application (Advagen Pharma Ltd.)

  The FDA approved Advagen Pharma Ltd.'s original application for potassium chloride, enabling a generic product to treat potassium deficiency…

• FDA approval · 2023-05-05
  FDA Approved: POTASSIUM CHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

  The FDA approved Lupin Pharmaceuticals' supplemental application for Potassium Chloride, approving changes to the product's labeling.

• FDA approval · 2023-03-07
  FDA Approved: POTASSIUM CHLORIDE — Original Application (BPI Labs LLC)

  FDA approves the original application for Potassium Chloride by BPI Labs LLC (generic potassium chloride).

• FDA approval · 2023-02-15
  FDA Approved: POTASSIUM CHLORIDE — Supplemental Application (Advagen Pharma Ltd)

  FDA approved a supplemental application for Potassium Chloride by Advagen Pharma Ltd.

• FDA approval · 2022-12-30
  FDA Approved: POTASSIUM CHLORIDE — Original Application (Guardian Drug Company)

  The FDA approved Guardian Drug Company's original application for potassium chloride, a potassium supplement used to treat or prevent potass…

• FDA approval · 2022-12-19
  FDA Approved: POTASSIUM CHLORIDE — Supplemental Application (AvPAK)

  FDA approved a supplemental application for Potassium Chloride (generic) from AvPAK under ANDA210041. This action updates regulatory approva…

• FDA approval · 2022-12-02
  FDA Approved: POTASSIUM CHLORIDE — Supplemental Application (Fresenius Kabi USA, LLC)

  FDA has approved a supplemental application for potassium chloride from Fresenius Kabi USA, LLC. This approval updates the product’s labelin…

• FDA approval · 2022-12-02
  FDA Approved: POTASSIUM CHLORIDE — Supplemental Application (Fresenius Kabi USA, LLC)

  FDA approved a supplemental application for Potassium Chloride from Fresenius Kabi USA, LLC, approving changes to an already approved produc…